De Wals P - Search Results

1

Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.

Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Brisson M, et al. Among authors: de wals p, de serres g. Vaccine. 2010 Apr 26;28(19):3385-97. doi: 10.1016/j.vaccine.2010.02.079. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20199763

2

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada.

Brisson M, Van de Velde N, De Wals P, Boily MC. Brisson M, et al. Among authors: de wals p. Vaccine. 2007 Jul 20;25(29):5399-408. doi: 10.1016/j.vaccine.2007.04.086. Epub 2007 May 22. Vaccine. 2007. PMID: 17561316

3

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.

Brisson M, Pellissier JM, Camden S, Quach C, De Wals P. Brisson M, et al. Among authors: de wals p. Hum Vaccin. 2008 May-Jun;4(3):238-45. doi: 10.4161/hv.4.3.5686. Epub 2010 May 25. Hum Vaccin. 2008. PMID: 18382137

4

Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.

Gilca V, De Serres G, Boulianne N, De Wals P, Murphy D, Trudeau G, Massé R, Duval B. Gilca V, et al. Among authors: de wals p, de serres g. Vaccine. 2009 Oct 9;27(43):6048-53. doi: 10.1016/j.vaccine.2009.07.100. Epub 2009 Aug 13. Vaccine. 2009. PMID: 19683086 Clinical Trial.

5

Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study.

Drolet M, Zhou Z, Sauvageau C, DeWals P, Gilca V, Amini R, Bénard É, Brisson M. Drolet M, et al. CMAJ. 2019 Aug 26;191(34):E932-E939. doi: 10.1503/cmaj.190274. CMAJ. 2019. PMID: 31451524 Free PMC article.

6

Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.

Brisson M, Van de Velde N, De Wals P, Boily MC. Brisson M, et al. Among authors: de wals p. CMAJ. 2007 Aug 28;177(5):464-8. doi: 10.1503/cmaj.061709. Epub 2007 Aug 20. CMAJ. 2007. PMID: 17709404 Free PMC article.

7

Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: methodological difficulties and imperfect solutions.

De Wals P, Deceuninck G, Ouakki M, Boulianne N, De Serres G, Danzig L. De Wals P, et al. Among authors: de serres g. Vaccine. 2009 May 21;27(24):3223-7. doi: 10.1016/j.vaccine.2009.02.055. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19446195

8

Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine.

Gilca V, De Serres G, Boulianne N, Murphy D, De Wals P, Ouakki M, Trudeau G, Massé R, Dionne M. Gilca V, et al. Among authors: de wals p, de serres g. Vaccine. 2013 Jan 7;31(3):448-51. doi: 10.1016/j.vaccine.2012.11.037. Epub 2012 Dec 1. Vaccine. 2013. PMID: 23206974

9

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

Deceuninck G, De Serres G, Boulianne N, Lefebvre B, De Wals P. Deceuninck G, et al. Among authors: de wals p, de serres g. Vaccine. 2015 May 28;33(23):2684-9. doi: 10.1016/j.vaccine.2015.04.005. Epub 2015 Apr 15. Vaccine. 2015. PMID: 25887086

10

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

De Wals P, Deceuninck G, De Serres G. De Wals P, et al. Among authors: de serres g. Vaccine. 2016 Apr 19;34(18):2053-4. doi: 10.1016/j.vaccine.2015.06.104. Vaccine. 2016. PMID: 27021043 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters